Basic Information
POLARINE TABLET
TABLET
Regulatory Information
SIN07612P
January 18, 1994
Pharmacy Only
Therapeutic
ORAL
August 10, 2023
May 30, 2025
XR06AB52
Company Information
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
Strength: 60 mg
Strength: 2 mg
Detailed Information
Contraindications
**Contraindications:** This formula is contraindicated in patients exhibiting hypersensitivity to any of the components. Antihistamine are contraindicated in patients receiving monoamine oxidase inhibitors since these agents prolong and intensify the anticholinergic effects of anti-histamines. Antihistamines should not be used to treat lower respiratory tract symptoms. Sympathomimetic preparations are contraindicated in patients with severe hypertension, severe coronary artery disease and patients receiving MAO inhibitor therapy due to potentiation of the pressor effects of pseudoephedrine.
Indication Information
**Indications:** It is indicated in nasal and respiratory congestion, common cold, acute sinusitis, allergic rhinitis.